Human herpesvirus 6 immediate-early 1 protein is a sumoylated nuclear phosphoprotein colocalizing with promyelocytic leukemia protein-associated nuclear bodies

被引:43
作者
Gravel, A
Gosselin, J
Flamand, L
机构
[1] CHU Laval, Res Ctr, Rheumatol & Immunol Res Ctr, Virol Lab, Quebec City, PQ G1V 4G2, Canada
[2] CHU Laval, Res Ctr, Rheumatol & Immunol Res Ctr, Lab Viral Immunol, Quebec City, PQ G1V 4G2, Canada
[3] Univ Laval, Fac Med, Quebec City, PQ G1V 4G2, Canada
关键词
D O I
10.1074/jbc.M200836200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immediate-early (IE) proteins are the first proteins expressed following viral entry and play a crucial role in the initiation of infection. We report the cloning and characterization of a full-length IE1 transcript and protein (IE1B) from human herpesvirus 6 (HHV-6) variant B. The IE1B transcript consists of five exons (3720 nucleotides), three of which are coding for the IE1 protein. The 1078-amino acid-long IE1B protein is 62% identical and 75% similar to the 941-amino acid IE1 from HHV-6 variant A. IE1B protein can be detected at 4 h post-infection (P.I.), and it is distributed as small intranuclear structures. The maximal number of IE1 bodies (similar to10-12/nucleus) is detected at 12 h P.I. after which the IE1 bodies condense into 1-3 larger entities by 24-48 h P.I. During infection the IE1B protein is phosphorylated on serine and threonine residues. IE1B undergoes further post-translational modification with its conjugation to the small ubiquitin-like modifier (SUMO-1) peptide. IE1B colocalizes with SUMO-1 and promyelocytic leukemia nuclear bodies during infection as well as in transfection experiments. Finally, IE1 from variant B is a weaker transactivator than IE1 from variant A, when assayed using heterologous promoters. Overall, the characterization of the HHV-6 IE1B protein presented highlights the similarity and divergence between IE1 from both variants and provides useful information pertaining to the early phase of infection.
引用
收藏
页码:19679 / 19687
页数:9
相关论文
共 77 条
[1]   HUMAN HERPESVIRUS-6 STRAIN GROUPS - A NOMENCLATURE [J].
ABLASHI, D ;
AGUT, H ;
BERNEMAN, Z ;
CAMPADELLIFIUME, G ;
CARRIGAN, D ;
CECCERININELLI, L ;
CHANDRAN, B ;
CHOU, S ;
COLLANDRE, H ;
CONE, R ;
DAMBAUGH, T ;
DEWHURST, S ;
DILUCA, D ;
FOATOMASI, L ;
FLECKENSTEIN, B ;
FRENKEL, N ;
GALLO, R ;
GOMPELS, U ;
HALL, C ;
JONES, M ;
LAWRENCE, G ;
MARTIN, M ;
MONTAGNIER, L ;
NEIPEL, F ;
NICHOLAS, J ;
PELLETT, P ;
RAZZAQUE, A ;
TORRELLI, G ;
THOMSON, B ;
SALAHUDDIN, S ;
WYATT, L ;
YAMANISHI, K .
ARCHIVES OF VIROLOGY, 1993, 129 (1-4) :363-366
[2]   Human herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report [J].
Ablashi, DV ;
Lapps, W ;
Kaplan, M ;
Whitman, JE ;
Richert, JR ;
Pearson, GR .
MULTIPLE SCLEROSIS, 1998, 4 (06) :490-496
[3]   Epstein-Barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies [J].
Adamson, AL ;
Kenney, S .
JOURNAL OF VIROLOGY, 2001, 75 (05) :2388-2399
[4]   The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-asscciated nuclear bodies at very early times in infected permissive cells [J].
Ahn, JH ;
Hayward, GS .
JOURNAL OF VIROLOGY, 1997, 71 (06) :4599-4613
[5]   Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML [J].
Ahn, JH ;
Brignole, EJ ;
Hayward, GS .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (08) :4899-4913
[6]   Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9 [J].
Ahn, JH ;
Xu, YX ;
Jang, WJ ;
Matunis, MJ ;
Hayward, GS .
JOURNAL OF VIROLOGY, 2001, 75 (08) :3859-3872
[7]  
ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
[8]   FATAL FULMINANT-HEPATITIS IN AN INFANT WITH HUMAN HERPESVIRUS-6 INFECTION [J].
ASANO, Y ;
YOSHIKAWA, T ;
SUGA, S ;
YAZAKI, T ;
KONDO, K ;
YAMANISHI, K .
LANCET, 1990, 335 (8693) :862-863
[9]   SEQUENCE REQUIREMENTS FOR ACTIVATION OF THE HIV-1 LTR BY HUMAN CYTOMEGALOVIRUS [J].
BIEGALKE, BJ ;
GEBALLE, AP .
VIROLOGY, 1991, 183 (01) :381-385
[10]  
Bonura F, 1999, MICROBIOLOGICA, V22, P161